跳至主要内容
临床试验/TCTR20210921004
TCTR20210921004尚未招募1 期

Efficacy and Sustainability of Diabetes Specific Formula (Metabolic Sauver) on Weight Reduction and Glycemic Control among Overweight and Obese Patients with Type-2 Diabetes Mellitus as Compared to Dietary Consultation

Powerlife (M) Sdn. Bhd.0 个研究点目标入组 156 人开始时间: 2021年9月21日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
156

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Diagnosed with T2DM for at least 6 months with baseline HbA1c levels between 7.5% and 12% for the past three months
  • 2. Overweight or obese with BMI more than or equals to 25kg/m2
  • 3. On stable doses of any oral hypoglycemic agents for the past 3 months

排除标准

  • 1. on insulin treatment
  • 2. With chronic kidney disease or on continuous ambulatory peritoneal dialysis or hemodialysis (GFR< 30 ml/min/1.73 m2).
  • 3. With hepatic diseases (ALT > 120 IU/L)
  • 4. With history of chronic alcohol abuse
  • 5. Pregnant and lactating women
  • 6. Currently consuming any weight reduction products or any sliming prescriptions
  • 7. Currently involving in weight loss programs
  • 8. Diagnosed with COVID-19

研究者

发起方
Powerlife (M) Sdn. Bhd.

相似试验